Eledon completes $57.5 million financing to advance drug trials Jan 8, 2026 04:07PM
Eledon reports early diabetes trial results for tegoprubart drug Nov 18, 2025 04:05PM
Eledon Pharamceuticals (ELDN) PT Lowered to $8 at Guggenheim Nov 18, 2025 06:31AM
Eledon Pharamceuticals (ELDN) PT Lowered to $5 at Leerink Partners Nov 10, 2025 04:37AM
Increasing unusual option volume: ELDN TAC MYLS WRBY PUBM MLYS PLNT MTSR DAY Nov 6, 2025 10:53AM


Aug 14, 2025 05:43PM Eledon Pharmaceuticals, Inc. (ELDN) Tops Q2 EPS by 9c
Jul 25, 2025 08:56AM Craig-Hallum Starts Eledon Pharamceuticals (ELDN) at Buy
Jul 10, 2025 07:13AM Cantor Fitzgerald Reiterates Overweight Rating on Eledon Pharamceuticals (ELDN)
Jun 26, 2025 07:03AM Cantor Fitzgerald Reiterates Overweight Rating on Eledon Pharamceuticals (ELDN)
Jun 18, 2025 06:43AM H.C. Wainwright Assumes Eledon Pharamceuticals (ELDN) at Buy
May 15, 2025 07:25AM Cantor Fitzgerald Reiterates Overweight Rating on Eledon Pharamceuticals (ELDN)
May 14, 2025 06:40PM Eledon Pharmaceuticals, Inc. (ELDN) Tops Q1 EPS by 17c
Feb 7, 2025 10:00AM Eledon Pharmaceuticals (ELDN) Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
Nov 20, 2024 07:26AM H.C. Wainwright Reiterates Buy Rating on Eledon Pharamceuticals (ELDN)
Nov 13, 2024 06:24AM Eledon Pharmaceuticals, Inc. (ELDN) Reports In-Line Q3 EPS
Oct 29, 2024 07:46AM Eledon Pharmaceuticals (ELDN) Prices $85M Offering at $3.65/sh
Oct 29, 2024 07:45AM Eledon Pharma (ELDN) Announces Positive Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation
Sep 20, 2024 04:19PM Eledon Pharmaceuticals (ELDN) Files $250M Mixed Shelf